Skip to main content

Trump's First 100 Days, Part IV: AMCs, Life Sciences, Pharma, and Medical Device Companies

AHLA

Feb
10
2017

Date: February 10, 2017

Time: 2:00PM

Location: Webinar

 

The incoming Trump Administration's policies could have a great and lasting impact on the Affordable Care Act. This four-part webinar series will look at these potential impacts on numerous groups, including providers, payers, the uninsured, those on Medicare or Medicaid, and medical device companies, among others.

In Trump's first 100 days, the 21st Century Cures Act, existing regulatory and research priorities, and expected administrative changes will all impact the research and life science community. Part IV will discuss the key areas of expected change and implementation challenges under a new Administration.

To register, please click here.

Speakers

Bethany J. Hills is recognized for her experience and insight on FDA matters. At Mintz, she advises health care providers on pre- and post-market issues. Bethany also helps international and US companies enter and navigate the US health care market.